Sedatives/ Hypnotics for Mental Disorder: 28.0% of denials overturned
In 25 California IMR decisions from 2004 to 2025, reviewers overturned 7 (28.0%). In the last five years: 27.3% of 11. 22 were medical-necessity disputes, 3 experimental/investigational.
By year (last five)
| Year | Decisions | Overturned |
|---|---|---|
| 2021 | 3 | 33.3% |
| 2022 | 3 | 0.0% |
| 2023 | 2 | 0.0% |
| 2024 | 2 | 50.0% |
| 2025 | 1 | 100.0% |
What the findings mention
| What the findings mention | Decisions | Overturned | All decisions here |
|---|---|---|---|
| Published evidence citedThe findings refer to peer-reviewed or published evidence. | 9 | 22.2% | 28.0% |
| Prior therapies failedThe findings mention treatments that were tried without adequate response. | 9 | 33.3% | 28.0% |
| Records did not supportThe findings say the documentation did not show what was needed (usually an upheld denial). | 8 | 0.0% | 28.0% |
| Step therapy or fail-firstThe findings mention a fail-first requirement. | 4 | 25.0% | 28.0% |
| Alternatives contraindicatedThe findings mention a contraindication to the plan's preferred option. | 3 | 0.0% | 28.0% |
| FDA approval or off-label use discussedThe findings discuss the FDA label status of the treatment. | 3 | 33.3% | 28.0% |
Keyword matches on the reviewer’s findings, not causes. A tag that appears mostly in overturned decisions is worth documenting in an appeal; it is not a guarantee.
From recent overturned decisions
“The physician reviewer found that Nature of Statutory Criteria/Case Summary: A patient has requested authorization and coverage for Ketalar. This patient has been diagnosed with recurrent and severe major depressive disorder (MDD). The patient has had various levels of care of treatment without significant benefit but has had significant improvement in symptoms from intravenous (IV) ketamine treatment received in the …”
“The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient requested authorization and coverage for intravenous (IV) ketamine therapy administered every other week.Chronic and treatment-refractory depression (TRD) courses are still a major challenge in the treatment of depression despite new treatment options. Systematic and structured treatment procedures, the diligent assessment of response at critical decision points, and timely …”
“Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for intravenous ketamine treatment (once every two weeks). At issue is whether the requested intravenous ketamine treatments (once every two weeks) to treat the enrollee’s mental health or substance use disorder are medically necessary as defined in Health and Safety code section 1374(a)(3)(A) set forth below. “Medically necessary …”
And one the reviewer upheld
“The physician reviewer found that Nature of Statutory Criteria/Case Summary: A patient has requested authorization and coverage for ketamine troches and/or intravenous (IV) ketamine infusion therapy. This patient presents with treatment-resistant depression and post-traumatic stress disorder (PTSD), which makes him a possible candidate for ketamine therapy. Given the trial and failure of multiple other modalities, including anti-depressants, cognitive behavioral therapy, …”
- California only: these are decisions by independent reviewers under California's IMR program (plans regulated by the Department of Managed Health Care). Other states and self-funded employer plans use different reviewers and rules.
- Selection: only denials that a member took all the way to IMR appear. Most denials are never appealed, and the ones that reach an external reviewer are not a random sample.
- Overturned means the reviewer disagreed with the plan; it does not mean the treatment worked or that a similar request will be approved.
- Argument tags are keyword matches on the reviewer's findings. They describe what the findings mention, not why the case was decided.
- Categories are DMHC's own labels (treatment sub-category and diagnosis category); 'Other' is a catch-all and is excluded from rankings.
Source: California Department of Managed Health Care, Independent Medical Review (IMR) Determinations, Trend (CHHS Open Data). Public California government data; Apellica's aggregates and tags are CC BY 4.0.
Questions
How often were Sedatives/ Hypnotics denials for Mental Disorder overturned?
In 25 California IMR decisions from 2004 to 2025, reviewers overturned 7 (28.0%). In the last five years: 27.3% of 11. 22 were medical-necessity disputes, 3 experimental/investigational.
What should an appeal document, based on these findings?
Whatever the plan's criteria ask for, shown in the record: the treatments already tried and their results, contraindications to the plan's preferred option, the guideline or evidence that supports the request, and the treating clinician's reasoning written to the criteria. The tag table shows which of these the reviewers mentioned most in overturned cases.
Does a California IMR result apply to my plan?
Only California plans regulated by the Department of Managed Health Care go to IMR. Other states and self-funded employer plans use different reviewers, but they weigh the same things.
Independent reviewers reverse plans when the record answers the criteria. Upload the denial letter; a senior reviewer reads it within 24 hours and tells you in writing whether it can be appealed and how. $0 upfront, 10% of what is recovered, nothing if we do not recover. Not a law firm.